Clevidipine for Vasospasm After Subarachnoid Hemorrhage

Trial Profile

Clevidipine for Vasospasm After Subarachnoid Hemorrhage

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Clevidipine (Primary)
  • Indications Cerebral vasospasm; Subarachnoid haemorrhage
  • Focus Therapeutic Use
  • Acronyms CLEVAS
  • Most Recent Events

    • 22 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top